Premium
Controlled Drug Release: Mesoporous Silica Nanoparticle‐based H 2 O 2 Responsive Controlled‐Release System Used for Alzheimer's Disease Treatment (Adv. Healthcare Mater. 3/2012)
Author(s) -
Geng Jie,
Li Meng,
Wu Li,
Chen Cuie,
Qu Xiaogang
Publication year - 2012
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201290014
Subject(s) - biocompatibility , mesoporous silica , drug delivery , nanoparticle , nanotechnology , materials science , in vivo , mesoporous material , controlled release , chemistry , catalysis , biochemistry , microbiology and biotechnology , metallurgy , biology
On page 332 , Xiaogang Qu and co‐workers present a novel strategy for Alzheimer's disease treatment using a H 2 O 2 ‐responsive controlled‐release system based on mesoporous silica nanoparticles. By taking advantage of the good biocompatibility, cellular uptake properties, and efficient intracellular release of metal chelators, the delivery system is promising for future in vivo biomedical applications.